Results from 2 randomized, double-blind, placebo-controlled studies of the novel nk1 receptor antagonist casopitant in patients with major depressive disorder

by Ratti, E., Bellew, K., Bettica, P., Bryson, H., Zamuner, S., Archer, G., Squassante, L., Bye, A., Trist, D., Krishnan, K.R., Fernandes, S.
Published 2014

Validation of aortic valve pressure gradient quantification using semi-automated 4D flow CMR pipeline

by Grafton-Clarke, C, Njoku, P, Aben, JP, Ledoux, L, Zhong, L, Westenberg, J, Swift, A, Archer, G, Wild, J, Hose, R, Flather, M, Vassiliou, VS, Garg, P
Published 2022

Full central neurokinin-1 receptor blockade is required for efficacy in depression: Evidence from orvepitant clinical studies

by Ratti, E., Bettica, P., Alexander, R., Archer, G., Carpenter, D., Evoniuk, G., Gomeni, R., Lawson, E., Lopez, M., Millns, H., Rabiner, E.A., Trist, D., Trower, M., Zamuner, S., Krishnan, R., Fava, M.
Published 2014